Live feed16:05:00·5dPRReleasevia QuantisnowProthena Announces Novo Nordisk Obtains Fast Track Designation from the U.S. FDA for Coramitug (PRX004) in ATTR Amyloidosis with CardiomyopathyByQuantisnow·Wall Street's wire, on your screen.PRTA· Prothena Corporation plcHealth Care
